The Scientist

» approvals and developmental biology

Most Recent

image: A Twist of Fate

A Twist of Fate

By | March 1, 2014

Once believed to be irrevocably differentiated, mature cells are now proving to be flexible, able to switch identities with relatively simple manipulation.

3 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: Meiosis Maven

Meiosis Maven

By | February 1, 2014

Fueled by her love of visual data and addicted to chromosomes, Abby Dernburg continues to study how homologous chromosomes find each other during gamete formation.

1 Comment

image: Unmasking Secret Identities

Unmasking Secret Identities

By | February 1, 2014

A tour of techniques for measuring DNA hydroxymethylation

2 Comments

image: Fish of Many Colors

Fish of Many Colors

By | January 23, 2014

Researchers seek insight into the pigmentation patterns of guppies and zebrafish.

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: Week in Review: January 6–10

Week in Review: January 6–10

By | January 10, 2014

Bacterial genes aid tubeworm settling; pigmentation of ancient reptiles; nascent neurons and vertebrate development; exploring simple synapses; slug-inspired surgical glue

0 Comments

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: About Face

About Face

By | October 25, 2013

Researchers show that genetic enhancer elements likely contribute to face shape in mice.

0 Comments

image: Progress for First Malaria Vaccine

Progress for First Malaria Vaccine

By | October 8, 2013

Following successful clinical trials, GlaxoSmithKline says it will submit its malaria vaccine for European regulatory approval.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland